Literature DB >> 16856172

Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine.

Robert K McNamara1, Aaron Logue, Kevin Stanford, Ming Xu, Jianhua Zhang, Neil M Richtand.   

Abstract

Accumulating evidence suggests that dopamine D3 receptor (D3R) stimulation is inhibitory to spontaneous and psychostimulant-induced locomotion through opposition of concurrent D1R and D2R-mediated signaling. To evaluate this model, we used homozygous D3R mutant mice and wild-type controls to investigate the role of the D3R in locomotor activity and stereotypy stimulated by acute amphetamine (AMPH) (0.2, 2.5, 5.0, 10.0 mg/kg). At the lowest dose tested (0.2 mg/kg), neither D3R mutant mice nor wild-type mice exhibited measurable change in locomotor activity or stereotypy relative to their respective saline-treated controls. D3R mutant mice exhibited a significantly greater increase in locomotor activity, but not stereotypy, relative to wild-type mice in response to treatment with AMPH 2.5 mg/kg. AMPH-induced locomotor activity and stereotypy were similar in both wild-type and D3R mutant mice at both the 5.0 and 10 mg/kg AMPH doses. These findings provide further support for an inhibitory role for the D3R in AMPH-induced locomotor activity, and demonstrate a more limited role for the D3R in modulating AMPH-induced stereotypy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16856172      PMCID: PMC1815379          DOI: 10.1002/syn.20315

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  38 in total

1.  Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses.

Authors:  A Zapata; J M Witkin; T S Shippenberg
Journal:  Neuropharmacology       Date:  2001-09       Impact factor: 5.250

2.  Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.

Authors:  K D Carr; N Yamamoto; M Omura; S Cabeza de Vaca; L Krahne
Journal:  Psychopharmacology (Berl)       Date:  2002-06-27       Impact factor: 4.530

3.  Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion.

Authors:  A M Ouagazzal; I Creese
Journal:  Pharmacol Biochem Behav       Date:  2000-11       Impact factor: 3.533

Review 4.  Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs.

Authors:  J N Joyce
Journal:  Pharmacol Ther       Date:  2001 May-Jun       Impact factor: 12.310

Review 5.  Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.

Authors:  E Bezard; J M Brotchie; C E Gross
Journal:  Nat Rev Neurosci       Date:  2001-08       Impact factor: 34.870

Review 6.  Role of monoamine transporters in mediating psychostimulant effects.

Authors:  Evan L Riddle; Annette E Fleckenstein; Glen R Hanson
Journal:  AAPS J       Date:  2005-12-20       Impact factor: 4.009

7.  Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors.

Authors:  J D Joseph; Y-M Wang; P R Miles; E A Budygin; R Picetti; R R Gainetdinov; M G Caron; R M Wightman
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

8.  Cocaine effects on gene regulation in the striatum and behavior: increased sensitivity in D3 dopamine receptor-deficient mice.

Authors:  A R Carta; C R Gerfen; H Steiner
Journal:  Neuroreport       Date:  2000-08-03       Impact factor: 1.837

9.  Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.

Authors:  C Betancur; I Lépée-Lorgeoux; M Cazillis; D Accili; S Fuchs; W Rostène
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

10.  Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out mice.

Authors:  D Vallone; M Pignatelli; G Grammatikopoulos; L Ruocco; Y Bozzi; H Westphal; E Borrelli; A G Sadile
Journal:  Behav Brain Res       Date:  2002-03-10       Impact factor: 3.332

View more
  24 in total

1.  Alterations in postnatal neurogenesis and dopamine dysregulation in schizophrenia: a hypothesis.

Authors:  Dragos Inta; Andreas Meyer-Lindenberg; Peter Gass
Journal:  Schizophr Bull       Date:  2010-11-19       Impact factor: 9.306

2.  D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.

Authors:  Xueliang Fan; Ming Xu; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2009-10-22       Impact factor: 5.996

3.  Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens.

Authors:  Daniel F Manvich; Alyssa K Petko; Rachel C Branco; Stephanie L Foster; Kirsten A Porter-Stransky; Kristen A Stout; Amy H Newman; Gary W Miller; Carlos A Paladini; David Weinshenker
Journal:  Neuropsychopharmacology       Date:  2019-03-16       Impact factor: 7.853

4.  Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens.

Authors:  Jie Zhu; Yanjiong Chen; Na Zhao; Guofen Cao; Yonghui Dang; Wei Han; Ming Xu; Teng Chen
Journal:  J Neurosci Res       Date:  2012-04       Impact factor: 4.164

5.  Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine.

Authors:  Kathryn D Fischer; Alex C W Houston; Rajeev I Desai; Michelle R Doyle; Jack Bergman; Maha Mian; Rebekah Mannix; David L Sulzer; Se Joon Choi; Eugene V Mosharov; Nathaniel W Hodgson; Anita Bechtholt; Klaus A Miczek; Paul A Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  2018-02-22       Impact factor: 4.530

6.  Working memory span capacity improved by a D2 but not D1 receptor family agonist.

Authors:  Isadore S Tarantino; Richard F Sharp; Mark A Geyer; Jessica M Meves; Jared W Young
Journal:  Behav Brain Res       Date:  2011-01-11       Impact factor: 3.332

7.  Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine.

Authors:  Alison A Williams; Wendy M Ingram; Sarah Levine; Jack Resnik; Christy M Kamel; James R Lish; Diana I Elizalde; Scott A Janowski; Joseph Shoker; Alexey Kozlenkov; Javier González-Maeso; Amelia L Gallitano
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

Review 8.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

Review 9.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

10.  Cocaine self-administration in dopamine D₃ receptor knockout mice.

Authors:  S Barak Caine; Morgane Thomsen; Andrew C Barrett; Gregory T Collins; Peter Grundt; Amy Hauck Newman; Paul Butler; Ming Xu
Journal:  Exp Clin Psychopharmacol       Date:  2012-08-06       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.